Search

Your search keyword '"Prostate cancer -- Patient outcomes"' showing total 613 results
Start Over Descriptor "Prostate cancer -- Patient outcomes"
613 results on '"Prostate cancer -- Patient outcomes"'

2. Johnson & Johnson announces ERLEADA provided overall survival benefit

Subjects
Johnson & Johnson, Prostate cancer -- Patient outcomes, Pharmaceutical industry -- Analysis, Business, News, opinion and commentary, Erleada (Medication)
Abstract

Johnson & Johnson announced the results of a real-world, head-to-head study showing that ERLEADA provided a statistically significant overall survival benefit at 24 months compared to enzalutamide in patients with [...]

Published
2024

3. New Prostate Cancer Research from Yamagata City Hospital Saiseikan Described (Treatment outcome of localized prostate cancer using transperineal ultrasound image-guided radiotherapy)

Subjects
Oncology, Experimental -- Analysis, Prostate cancer -- Patient outcomes, Cancer -- Research, Radiotherapy -- Analysis, Physical fitness -- Analysis, Health
Abstract

2024 AUG 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on prostate cancer have been published. According to news [...]

Published
2024

4. Research from Chiba University Graduate School of Medicine Broadens Understanding of Prostatectomy (Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone ...)

Subjects
Prostate cancer -- Patient outcomes, Magnetic resonance imaging -- Reports, Medical colleges -- Reports, Physical fitness -- Reports, Health
Abstract

2024 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on prostatectomy are presented in a new report. According to [...]

Published
2024

5. Studies in the Area of Prostate Cancer Reported from German Cancer Society (Transforming a Large-Scale Prostate Cancer Outcomes Dataset to the OMOP Common Data Model-Experiences from a Scientific Data Holder's Perspective)

Subjects
Oncology, Experimental -- Models, Prostate cancer -- Patient outcomes, Cancer -- Research, Physical fitness -- Models, Health
Abstract

2024 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in prostate cancer. According to news reporting from [...]

Published
2024

6. Plant-Based Diet May Aid Prostate Cancer Outcomes

Subjects
Oncology, Experimental -- Reports, Prostate cancer -- Patient outcomes, Cancer -- Research, Health
Abstract

HealthDay News — Consuming a primarily plant-based diet may be associated with better cancer-specific health outcomes among men with prostate cancer, according to a study published online May 1 in [...]

Published
2024

7. Outcomes4Me and the National Comprehensive Cancer Network (NCCN) Expand Collaboration to Improve Outcomes for Patients Diagnosed with Prostate Cancer

Subjects
Prostate cancer -- Patient outcomes, Cancer patients -- Patient outcomes, Practice guidelines (Medicine), Lung cancer, Non-small cell -- Patient outcomes, Evidence-based medicine, General interest, News, opinion and commentary, National Comprehensive Cancer Network
Abstract

BOSTON: Outcomes4Me Inc. has issued the following news release: Outcomes4Me Inc., the developer of the first direct-to-patient, personalized, and evidence-based cancer navigation platform, and the National Comprehensive Cancer Network(r) (NCCN(r)) [...]

Published
2024

8. Outcomes4Me and the National Comprehensive Cancer Network (NCCN) Expand Collaboration to Improve Outcomes for Patients Diagnosed with Prostate Cancer

Subjects
Prostate cancer -- Patient outcomes, Cancer patients -- Patient outcomes, Practice guidelines (Medicine), Evidence-based medicine, Business, News, opinion and commentary, National Comprehensive Cancer Network
Abstract

Enhanced integration fuels the rapid growth of this first-of-its kind platform and related initiative between Outcomes4Me and NCCN, leveraging technology to empower cancer patients with personalized clinical information and resources [...]

Published
2024

9. Post-RARP Outcomes Worse for Prostate Cancer of Unconventional Histology

Author

Persaud, Natasha

Subjects
Prostate cancer -- Patient outcomes, Health
Abstract

Oncologic and functional outcomes after robot-assisted radical prostatectomy (RARP) are worse for men with prostate cancer of unconventional histology, a new study finds. Jeremy Yuen-Chun Teoh, MD, of The Chinese [...]

Published
2024

10. Adam Jogee ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of a screening programme for prostate cancer on patient outcomes

Subjects
Prostate-specific antigen, Prostate cancer -- Patient outcomes, Cancer patients -- Patient outcomes, Cancer -- Diagnosis, Business, international
Abstract

London: UK Parliament has issued the following written answer: Answer Andrew Gwynne Answered on 11 October 2024 Screening for prostate cancer is currently not recommended by the UK National Screening [...]

Published
2024

11. PFIZER'S TALZENNA[R] IN COMBINATION WITH XTANDI[R] PROLONGS OVERALL SURVIVAL IN PHASE 3 TALAPRO-2 TRIAL

Subjects
Xtandi (Medication), Talzenna (Medication), Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Sugars -- Analysis, Monosaccharides -- Analysis, Pharmaceutical industry -- Analysis, Pfizer Inc.
Abstract

NEW YORK, NY -- The following information was released by Pfizer Inc.: First and only PARP inhibitor plus ARPI combination to demonstrate statistically significant overall survival (OS) benefit in patients [...]

Published
2024

12. Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis

Subjects
Takeda Pharmaceutical Company Ltd. -- Product development, Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Antineoplastic agents -- Product development, Immunotherapy, Clinical trials, Pharmaceutical industry -- Product development, Antimitotic agents -- Product development, Business, international, Cabometyx (Medication) -- Product development
Abstract

(GLOBE NEWSWIRE via COMTEX) -- - Trial investigating Cabometyx(R) (cabozantinib) in combination with atezolizumab demonstrated a positive trend towards improvement for one of the primary endpoints of overall survival, but [...]

Published
2024

13. Cancer survival rates in UK lagging 25 years behind other European countries; Survival rates in Britain lag 25 years behind other European countries for certain cancers as experts say healthcare is at 'breaking point' due to 'political choices'

Subjects
Colon cancer -- Patient outcomes, Prostate cancer -- Patient outcomes, Cervical cancer -- Patient outcomes, Cancer -- Patient outcomes, General interest, News, opinion and commentary
Abstract

Byline: By, Martin Bagot Survival rates in Britain lag 25 years behind some European countries for common cancers. Survival rates for prostate, cervix and colon cancers are only reaching levels [...]

Published
2024

14. Studies from Huntsman Cancer Institute Yield New Data on Prostate Cancer (Mental health outcomes in a population-based cohort of patients with prostate cancer)

Subjects
United States. National Cancer Institute, Oncology, Experimental, Prostate cancer -- Patient outcomes, Cancer patients -- Patient outcomes, Mental health, Plastics industry, Cancer -- Research, Physical fitness, Health
Abstract

2023 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on prostate cancer. According to news reporting out [...]

Published
2023

15. City University of New York (CUNY) Graduate School of Public Health and Health Policy Researchers Release New Data on Prostate Cancer (Relationship between universal health insurance benefits and prostate cancer mortality in Colombia)

Subjects
Oncology, Experimental, Prostate cancer -- Patient outcomes, National health insurance, Cancer -- Research, Health care industry, Law, The City University of New York
Abstract

2024 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Health Insurance Law Weekly -- Investigators publish new report on prostate cancer. According to news originating from City [...]

Published
2024

17. Reports on Prostate Cancer from Case Western Reserve University Provide New Insights (Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: a Systematic Review and Meta-analysis)

Subjects
Medical research -- Analysis -- Reports, Medicine, Experimental -- Analysis -- Reports, Prostate cancer -- Patient outcomes, Cancer patients -- Patient outcomes, Physical fitness -- Analysis -- Reports, Health, Case Western Reserve University -- Reports
Abstract

2023 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Oncology - Prostate Cancer are presented in a new [...]

Published
2023

18. Add-On Prostate Radiotherapy for De Novo Low-Volume mCSPC Improves Outcomes

Author

Charnow, Jody A.

Subjects
Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Radiotherapy, Health
Abstract

Adding prostate radiotherapy (RT) to intensified systemic therapy improves outcomes in de novo metastatic castration-sensitive prostate cancer (mCSPC) with low metastatic burden, according to research presented at the ASCO Annual [...]

Published
2023

19. Researcher at Fred Hutchinson Cancer Research Center Publishes Research in Prostate Cancer (Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer)

Subjects
Oncology, Experimental, Prostate cancer -- Patient outcomes, Cancer -- Research, Health, Fred Hutchinson Cancer Research Center
Abstract

2024 JUN 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on prostate cancer. According to news reporting originating from [...]

Published
2024

20. New Findings from Emory University Describe Advances in Prostatectomy (An Integrated Radiology-pathology Machine Learning Classifier for Outcome Prediction Following Radical Prostatectomy: Preliminary Findings)

Subjects
United States. National Institutes of Health, Prostate-specific antigen, Prostate cancer -- Patient outcomes, Machine learning, Surgery, Health, Emory University
Abstract

2024 JUN 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Surgery - Prostatectomy have been published. According to news [...]

Published
2024

21. New Veterans Health Study Findings Have Been Reported by Researchers at Veterans Affairs Salt Lake City Health Care System (Adrenal-permissive Germline hsd3b1 Allele and Prostate Cancer Outcomes)

Subjects
United States. Veterans Health Administration, Urban health, Prostate cancer -- Patient outcomes, Enzymes, Testosterone, Business, Health, Health care industry
Abstract

2024 MAY 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in Veterans Health. According to news reporting from Salt Lake City, [...]

Published
2024

22. Medical Centre of Postgraduate Education Researchers Publish New Data on Ductal Carcinoma In Situ (Prostate Cancer Morphologies: Cribriform Pattern and Intraductal Carcinoma Relations to Adverse Pathological and Clinical Outcomes-Systematic ...)

Subjects
Oncology, Experimental, Medical centers, Prostate cancer -- Patient outcomes, Cancer -- Patient outcomes -- Research, Carcinoma, Ductal -- Patient outcomes, Physical fitness, Health
Abstract

2023 APR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on ductal carcinoma in situ have been presented. According to [...]

Published
2023

23. Overall Cancer Mortality Continued to Decline From 2019 to 2020

Subjects
Prostate cancer -- Patient outcomes, Mortality -- Reports, Cancer -- Patient outcomes, Health
Abstract

(HealthDay News) — Overall cancer mortality is continuing to decline, according to a study published online in CA: A Cancer Journal for Clinicians. Rebecca L. Siegel, MPH, from the American [...]

Published
2023

25. Reports from Duke Cancer Institute Highlight Recent Findings in Prostate Cancer (Real-world Overall Survival With Abiraterone Acetate Versus Enzalutamide In Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer)

Subjects
Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Chemotherapy -- Analysis, Cancer -- Chemotherapy, Acetates -- Analysis, Business, Health, Health care industry
Abstract

2024 APR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting from [...]

Published
2024

26. Kyoto Prefectural University of Medicine Researchers Broaden Understanding of Prostate Cancer (The influence of Gleason score 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy)

Subjects
Oncology, Experimental -- Reports, Prostate cancer -- Patient outcomes, Cancer -- Research, Radiotherapy -- Reports, Health
Abstract

2024 APR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New study results on prostate cancer have been published. According to news reporting [...]

Published
2024

27. New Findings from Portuguese Oncology Institute in the Area of Prostate Cancer Reported (Deregulated Mirnas In Enzalutamide Resistant Prostate Cancer: a Comprehensive Review of Key Molecular Alterations and Clinical Outcomes)

Subjects
Prostate cancer -- Patient outcomes, Deregulation -- Portugal, Health
Abstract

2024 MAR 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting [...]

Published
2024

29. Novel Drug Improves Outcomes vs Bicalutamide in Metastatic Hormone-Sensitive Prostate Cancer

Author

Charnow, Jody A.

Subjects
Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Hormones, Bicalutamide, Health
Abstract

SHR3680, an investigational oral androgen receptor inhibitor (ARI), may be more effective than the first-generation ARI bicalutamide in patients with high-volume metastatic hormone-sensitive prostate cancer (mHSPC), according to research presented [...]

Published
2022

30. Reports Outline Prostate Cancer Findings from University of Toronto (A Distance-based, Randomized Controlled Trial for Reducing Sedentary Behavior Among Prostate Cancer Survivors: a Study Protocol)

Subjects
Oncology, Experimental, Cancer survivors -- Care and treatment -- Behavior, Psychiatric counseling -- Testing, Prostate cancer -- Patient outcomes, Sedentary behavior -- Health aspects, Behavior modification -- Testing, Cancer -- Research, Health
Abstract

2022 JUN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Prostate Cancer are discussed in a new [...]

Published
2022

31. 5-ARIs Do Not Increase Prostate Cancer Mortality

Author

Persaud, Natasha

Subjects
Oncology, Experimental, Prostate cancer -- Patient outcomes, Mortality -- Sweden, Cancer -- Research, Dutasteride, Health
Abstract

Use of 5-alpha-reductase inhibitors (5-ARIs) does not increase the risk of dying from prostate cancer, investigators of a Swedish population-based study reported at the American Urological Association’s 2022 annual meeting [...]

Published
2022

32. Investigators from University Medical Centre Goettingen Zero in on Erectile Dysfunction (Impact of Multiparametric Magnetic Resonance Imaging Targeted Biopsy On Functional Outcomes In Patients Following Robot-assisted Laparoscopic Radical ...)

Subjects
Oncology, Experimental, Laparoscopy, Medical centers, Laparoscopic surgery, Prostate cancer -- Patient outcomes, Impotence -- Patient outcomes, Magnetic resonance imaging, Robots, Cancer -- Research, Robot, Business, Health, Health care industry
Abstract

2024 JAN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Genital Diseases and Conditions - Erectile Dysfunction are presented in a new [...]

Published
2024

33. Statin Use Not Associated With Survival Benefits in mCRPC Patients

Author

Ernst, Diana

Subjects
Prostate cancer -- Patient outcomes, Statins, Health
Abstract

Statin use does not appear to affect overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC), according to findings presented at the 2022 American Society of Clinical Oncology (ASCO) [...]

Published
2022

34. Niraparib With Abiraterone + Prednisone Improves Outcomes in HRR BM+ Metastatic Castration Resistant Prostate Cancer

Author

Park, Brian

Subjects
Oncology, Experimental, Corticosteroids, Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Prednisone, Cancer -- Research, Health
Abstract

For patients with metastatic castration-resistant prostate cancer (mCRPC) with homologous recombinant repair (HRR) gene alterations, treatment with niraparib in combination with abiraterone acetate plus prednisone (AAP) as first-line therapy improved [...]

Published
2022

35. Niraparib With Abiraterone + Prednisone Improves Outcomes in HRR BM+ Metastatic Castration Resistant Prostate Cancer

Author

Park, Brian

Subjects
Oncology, Experimental, Corticosteroids, Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Prednisone, Cancer -- Research, Health
Abstract

For patients with metastatic castration-resistant prostate cancer (mCRPC) with homologous recombinant repair (HRR) gene alterations, treatment with niraparib in combination with abiraterone acetate plus prednisone (AAP) as first-line therapy improved [...]

Published
2022

36. Early Salvage Radiation After RP Improves Outcomes in Relapsed Prostate Cancer

Author

Persaud, Natasha

Subjects
Prostate cancer -- Patient outcomes, Cancer patients -- Patient outcomes, Metastasis -- Patient outcomes, Diseases -- Relapse, Radiation, Medical colleges, Health
Abstract

Initiating salvage radiation therapy (RT) early after biochemical recurrence of prostate cancer following radical prostatectomy may prolong the time to metastasis, investigators reported at the ASCO Genitourinary Cancers Symposium 2022. [...]

Published
2022

37. Rachael Maskell ask the Secretary of State for Health and Social Care, what steps his Department is taking to help tackle inequalities in cancer outcomes between integrated care board areas

Subjects
Prostate cancer -- Patient outcomes, Lymphomas -- Patient outcomes, Cancer -- Care and treatment -- Patient outcomes, Business, international
Abstract

London: UK Parliament has issued the following written answer: Answer Helen Whately Answered on 3 July 2023 Reducing variation in cancer treatment is a strategic priority for the NHS Cancer [...]

Published
2023

38. Data on Prostate Cancer Reported by Researchers at Monash University (Neuroendocrine Cells In Prostate Cancer Correlate With Poor Outcomes: a Systematic Review and Meta-analysis)

Subjects
Oncology, Experimental, Biochemistry, Prostate cancer -- Patient outcomes, Cancer -- Research, Physical fitness, Health, Monash University
Abstract

2022 JAN 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Oncology - Prostate Cancer is the subject of a [...]

Published
2022

39. Long-Term Prostate Cancer Mortality Patterns Defined

Author

Charnow, Jody A.

Subjects
Prostate cancer -- Patient outcomes, Mortality -- Ontario, Epidemiology -- Reports, Health
Abstract

More than half of deaths from prostate cancer in the United States occur among men initially diagnosed with low-grade disease, according to the findings of a large, population-based study presented [...]

Published
2021

40. Research Institute and Hospital Researchers Broaden Understanding of Prostatectomy (Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy)

Subjects
Oncology, Experimental, Prostate cancer -- Patient outcomes, Cancer patients -- Patient outcomes, Radiotherapy, Cancer -- Research, Physical fitness, Surgery, Health
Abstract

2021 DEC 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on prostatectomy have been published. According to news originating [...]

Published
2021

41. Investigators from University of Wisconsin Have Reported New Data on Prostate Cancer (Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms In Metastatic Prostate Cancer)

Subjects
Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Physical fitness, Health, University of Wisconsin
Abstract

2021 NOV 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Prostate Cancer have been published. According [...]

Published
2021

42. Investigators at Cedars Sinai Medical Center Detail Findings in Veterans Health (Survival and Economic Impact of Rapid Prostate-specific Antigen Doubling Time In Patients With Nonmetastatic Castration-resistant Prostate Cancer)

Subjects
United States. Veterans Health Administration -- Analysis, Medical care, Cost of -- Economic aspects -- Analysis, Medical centers -- Analysis -- Economic aspects, Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Hospitals, Veterans' -- Economic aspects -- Analysis, Antigens -- Analysis -- Economic aspects, Veterans -- Economic aspects -- Analysis, Business, Health, Health care industry
Abstract

2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in Veterans Health. According to news reporting originating in Los Angeles, [...]

Published
2023

43. Researchers from Sun Yat-sen University Publish Research in Artificial Intelligence (Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic ...)

Subjects
Oncology, Experimental -- Usage, Artificial intelligence -- Usage, Prostate cancer -- Patient outcomes, Magnetic resonance imaging -- Usage, Cancer -- Research, Artificial intelligence, Health
Abstract

2023 SEP 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on artificial intelligence have been presented. According to news reporting from [...]

Published
2023

44. Studies from University of Milan Bicocca Update Current Data on Radiation Oncology (Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking)

Subjects
Tumors -- Patient outcomes, Prostate cancer -- Patient outcomes, Patient compliance, Radiation, Physical fitness, Health
Abstract

2021 OCT 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on radiation oncology. According to news reporting out [...]

Published
2021

45. California Northstate University College of Pharmacy Researchers Have Published New Data on Prostate Cancer (Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes)

Subjects
Oncology, Experimental -- Reports, Immunohistochemistry -- Reports, Prostate cancer -- Patient outcomes, Pharmacy -- Reports, Cancer -- Research, Physical fitness -- Reports, Health
Abstract

2021 OCT 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on prostate cancer have been published. According to news [...]

Published
2021

46. Researchers from City of Hope National Medical Center Report Findings in Prostate Cancer (Hormonal Manipulation In Androgen Signaling: a Narrative Review On Using Novel Androgen Therapy Agents To Optimize Clinical Outcomes and Minimize Side ...)

Subjects
Oncology, Experimental -- Reports, Medical centers -- Reports, Prostate cancer -- Patient outcomes, Cancer -- Care and treatment -- Research, Testosterone -- Reports, Physical fitness -- Reports, Health
Abstract

2021 SEP 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Prostate Cancer have been published. According [...]

Published
2021

47. CytoVeris and AdventHealth Central Florida Join Forces for Clinical Study to Improve Prostate Cancer Outcomes

Subjects
Oncology, Experimental, Prostate cancer -- Patient outcomes, Clinical trials, Cancer -- Research, Medical imaging equipment, Business, general
Abstract

FARMINGTON, Conn. (PRWEB) March 28, 2023 CytoVeris Inc., a medical device company developing AI-powered cancer imaging technologies to enable more precise surgical decision-making and improve patient outcomes, today announced the [...]

Published
2023

48. CytoVeris and AdventHealth Central Florida Join Forces for Clinical Study to Improve Prostate Cancer Outcomes

Subjects
Oncology, Experimental, Prostate cancer -- Patient outcomes, Clinical trials, Cancer -- Research, Business, News, opinion and commentary
Abstract

Study will explore how MarginASSURE, CytoVeris' AI-powered imaging device, can help surgeons detect cancer in near real-time FARMINGTON, Conn., March 28, 2023 /PRNewswire-PRWeb/ -- https://c212.net/c/link/?t=0&l=en&o=3820954-1&h=1206162159&u=https%3A%2F%2Fcytoveris.com%2F&a=CytoVeris+Inc., a medical device company developing [...]

Published
2023

49. New data presented at ASCO GU confirm survival benefits and favorable safety profile of darolutamide across different subgroups of patients with metastatic hormone-sensitive prostate cancer

Subjects
Bayer AG -- Safety and security measures, Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Hormones -- Safety and security measures, Pharmaceutical industry -- Safety and security measures, Business, international
Abstract

Germany: Bayer AG has issued the following press release: New subgroup data from the Phase III ARASENS trial show overall survival (OS) benefits of darolutamide plus androgen deprivation therapy (ADT) [...]

Published
2023

50. Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer

Subjects
Corticosteroids, Prostate cancer -- Patient outcomes, Metastasis -- Patient outcomes, Prednisone, Acetates, Business, News, opinion and commentary
Abstract

Results from the Phase 3 MAGNITUDE study second interim analysis to be featured in an oral presentation at ASCO GU SAN FRANCISCO, Feb. 16, 2023 /PRNewswire/ -- The Janssen Pharmaceutical [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results